Literature DB >> 11768553

Substance use/abuse and anxiety sensitivity: what are the relationships?

G R Norton1.   

Abstract

The eight articles in this special issue on anxiety sensitivity (AS) and substance abuse provide provocative new information on the relationships, or lack of relationships, between AS and several types of substance use and abuse. The eight articles provide data that extend our understanding of the role of AS in substance abuse with younger people, people who use substances other than alcohol, people who have disorders comorbid with substance use disorders, and people who experience chronic headaches. In addition, one of the articles attempts to determine how AS develops in relationship to parental substance abuse. Finally, several of the studies show that the three Anxiety Sensitivity Index (ASI) subscales (physical concerns, social concerns, and psychological concerns) are uniquely associated with different aspects of substance use/abuse. Each of the articles is discussed as to its merits and potential domains that may require additional research. Finally, several general suggestions are provided for new directions that research on the relations of AS and substance use/abuse should take.

Entities:  

Mesh:

Year:  2001        PMID: 11768553     DOI: 10.1016/s0306-4603(01)00244-1

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  8 in total

1.  Locomotor activity does not predict individual differences in morphine self-administration in rats.

Authors:  Yayi Swain; Peter Muelken; Mark G LeSage; Jonathan C Gewirtz; Andrew C Harris
Journal:  Pharmacol Biochem Behav       Date:  2018-02-02       Impact factor: 3.533

2.  Associations among interpretation bias, craving, and abstinence self-efficacy in adults with substance use disorders.

Authors:  Courtney Beard; Andrew D Peckham; Margaret L Griffin; Roger D Weiss; Nadine Taghian; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-10-18       Impact factor: 4.492

3.  Anxiety sensitivity components in relation to alcohol and cannabis use, motives, and problems in treatment-seeking cigarette smokers.

Authors:  Casey R Guillot; Heidemarie Blumenthal; Michael J Zvolensky; Norman B Schmidt
Journal:  Addict Behav       Date:  2018-03-08       Impact factor: 3.913

4.  Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment.

Authors:  C W Lejuez; Michael J Zvolensky; Stacey B Daughters; Marina A Bornovalova; Autumn Paulson; Matthew T Tull; Kenneth Ettinger; Michael W Otto
Journal:  Behav Res Ther       Date:  2008-03-28

5.  Examining associations between cognitive-affective vulnerability and HIV symptom severity, perceived barriers to treatment adherence, and viral load among HIV-positive adults.

Authors:  Teresa M Leyro; Anka A Vujanovic; Marcel O Bonn-Miller
Journal:  Int J Behav Med       Date:  2015-02

Review 6.  Behavioral predictors of individual differences in opioid addiction vulnerability as measured using i.v. self-administration in rats.

Authors:  Yayi Swain; Jonathan C Gewirtz; Andrew C Harris
Journal:  Drug Alcohol Depend       Date:  2021-01-29       Impact factor: 4.492

7.  Withdrawal from escalated cocaine self-administration impairs reversal learning by disrupting the effects of negative feedback on reward exploitation: a behavioral and computational analysis.

Authors:  Peter Zhukovsky; Mickael Puaud; Bianca Jupp; Júlia Sala-Bayo; Johan Alsiö; Jing Xia; Lydia Searle; Zoe Morris; Aryan Sabir; Chiara Giuliano; Barry J Everitt; David Belin; Trevor W Robbins; Jeffrey W Dalley
Journal:  Neuropsychopharmacology       Date:  2019-04-06       Impact factor: 7.853

8.  High anxiety is a predisposing endophenotype for loss of control over cocaine, but not heroin, self-administration in rats.

Authors:  Ruth Dilleen; Yann Pelloux; Adam C Mar; Anna Molander; Trevor W Robbins; Barry J Everitt; Jeffrey W Dalley; David Belin
Journal:  Psychopharmacology (Berl)       Date:  2012-01-14       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.